New research brings hope of preventing vision loss from diabetesWednesday 02 December 2015
Diabetic retinopathy is the most serious complication of diabetes for your eyes, and it is estimated that 40% of people with type 1 diabetes and 20% with type 2 will develop some form of the disease. American researchers have now found that the drug Lucentis can be highly effective for treating the condition. In what is claimed to be the first major therapy advance in nearly 40 years, the discovery offers an alternative to the standard laser treatment which has been offered for the condition since the 1970’s. Although laser therapy is effective in improving central vision, it can cause deterioration in night sight and reduced side vision.
Jeffrey G. Gross, M.D, of the Carolina Retina Center in Columbia, South Carolina who chaired the study asserts that: “Lucentis should be considered a viable treatment option for people with proliferative diabetic retinopathy.”
- Science Daily:
New treatment options, better hope of preventing vision loss from diabetes.
- National Eye Institute:
Lucentis Effective for Proliferative Diabetic Retinopathy.
A Serious Blog
News and views from around the world on lighting, eyecare and eye conditions.
- A spark of genius - the history of the light bulb
- A worded world: Celebrating the Oxford English Dictionary's legacy
- High street cataract and glaucoma tests to reduce NHS waiting lists?
- Eye health resolutions for 2024: your comprehensive guide to preserving and enhancing eyesight
- The ultimate guide to the clock change – get prepared for the biannual time shift
Browse by label
- AMD Sight News
- Blue Light
- Diabetic Retinopathy
- Glaucoma Sight News
- Light News
- Light News Glaucoma Sight News
- Light News Sight News
- Literary Festivals
- Literary Festivals Literary News
- Literary News
- OCT Scans: A New Tool In Multiple Sclerosis Diagnosis
- Serious News
- Sight News
- Sight News AMD
- Sight News Blue Light
- Sight News Cataracts
- Sight News Glaucoma